Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J7170 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 99Other POS |
| Hospital Outpatient Group (APC) | APC 9257 - Inj., emicizumab-kxwh 0.5 mg |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 06360250 |
| Medicare Fee Schedule | $58.11 per 0.5 mg (October 2026 ASP)View Medicare rates for J7170 |
| Medicaid Fee Schedule | $57.285 median of the 8 states in the free previewView Medicaid rates for J7170 |
| Medicare Payment Limit | |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 50242092001 - Hemlibra (emicizumab) 30 mg/mL, injection, solution • 50242092101 - Hemlibra (emicizumab) 60 mg/.4mL, injection, solution • 50242092201 - Hemlibra (emicizumab) 105 mg/.7mL, injection, solution • 50242092301 - Hemlibra (emicizumab) 150 mg/mL, injection, solution • 50242092701 - Hemlibra Sol 1204ml |
National average reimbursement for HCPCS J7170 by major payers:

$54.95
BCBS / Anthem

$54.19
UnitedHealthcare

$57.31
Aetna

$56.05
Cigna
Choose a payer to see a sample of rates for HCPCS J7170.
Michael Glickman
Memorial Infectious Disease Group
Abdul Khuwaja
Alison Moskowitz
Msk Harrison
Jacob Mclean
Columbia University In The City Of New York
Justin Chen
Associated Clinicians Of East Texas, PLLC
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J7170 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J7170. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 50242092001-NDC | Hemlibra (emicizumab) 30 mg/mL, injection, solution |
| 50242092101-NDC | Hemlibra (emicizumab) 60 mg/.4mL, injection, solution |
| 50242092201-NDC | Hemlibra (emicizumab) 105 mg/.7mL, injection, solution |
| J7170-HCPCS | Injection, emicizumab-kxwh, 0.5 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J7170. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J7170 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J7170) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J7170 to APC 9257 (Inj., emicizumab-kxwh 0.5 mg). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J7170 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J7170 under these revenue codes: 0636 and 0250. A revenue code names the hospital department or charge category for the line; it does not change what the service is.